FDA Posts an Initial Batch of Four Deemed Final Administrative Orders for Over-the-Counter Drugs

U.S. Food and Drug Administration

WASHINGTON, D.C. — The following quote is attributed to Theresa M. Michele, M.D., director of the Office of Nonprescription Drugs in the FDA’s Center for Drug Evaluation and Research:

“Over-the-counter (OTC) drugs continue to save Americans time and money, and enable them to feel a sense of control over their own health. As part of OTC Monograph Reform under the Coronavirus Aid, Relief, and Economic Security Act, also called the CARES Act, the FDA will post deemed final administrative orders for OTC drugs.

“These orders were established by the CARES Act and took effect on the date of enactment of the CARES Act. Certain deemed final administrative orders are based on OTC monographs that were set forth in proposed and final rules prior to the CARES Act. These orders provide a baseline of conditions that are generally recognized as safe and effective for each OTC monograph therapeutic category.

READ:  Justice, Education Departments Issue Fact Sheet on Supporting Students at Risk of Self Harm During COVID-19 Era

“The deemed final orders will be posted using a phased approach, and publicly posted on the FDA’s new web portal, OTC [email protected]. This system also will provide the public with the ability to search for proposed administrative orders and final administrative orders that add, remove or change conditions for an OTC monograph.

“The FDA is committed to using the new tools provided by Congress as part of OTC Monograph Reform to promote innovation in the OTC marketplace and continue to help ensure the safety and effectiveness of OTC monograph drugs.”

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.